GMP Cell-based Bioassays and Potency Testing
Tailored cell-based bioassay or potency assays for biologics and biosimilars to meet the requirements of ICH Q6B and Good Manufacturing Practice (GMP)
- Cell migration assays
- Cell signalling assays
- Cell proliferation/inhibition assays
- Binding and/or competitive assays
Ligand and Receptor Binding Assays
Enzyme Linked Immuno-Sorbent Assays (ELISA) allows direct measurement of the biologic’s affinity to its target with typically, a robust performance.
We also apply Surface Plasmon Resonance (SPR) to measure product binding to its intended target and is particularly useful during product characterization, in particular for biosimilars as part of the comparability study to the innovator product.
Flexible, Multiple Assay Approaches for Monoclonal Antibodies
For products which have multiple MOAs, multiple assays may be needed to sufficiently demonstrate product efficacy as well as lot-to-lot comparability. We apply flexible approaches from an array of cell based assay platforms/models, as well as physico-chemical assays to designing potency assays for monoclonal antibodies and/or antibody drug conjugates (ADC’s) in order to assess their multiple MOA.
GMP Cell-based Assays or Potency Assay Applications
We apply phase-appropriate potency testing to wide array of biologic products including biosimilars, peptides, monoclonal antibodies, growth factors and cytokines and applications, such as biopharmaceutical stability testing and biologic drug product release testing.
- Candidate selection
- Assessment of clinical efficacy
- Product characterisation
- Robustness testing/design
- Biopharmaceutical stability testing
- Degradation products
- Formulation changes
- Support for production alterations
- Process intermediates characterisation
- Reference standard qualification
- Biologic product release testing
- Optimisation and transfer of assays
- Tracking and trending (establishment and maintenance of assays)
Our expertise in complex method development and validation for potency or biologic activity assessment can give you detailed insight into your biologic, helping to accelerate your development process. We can additionally provide extensive protein structure analysis from the primary structure through to higher-order structure, post-translational modifications and glycosylation studies. Our protein physicochemical property determination services include molecular weight and electrophoretic, chromatographic and spectroscopic profiles. Bringing quality and safety to life, we offer Total Quality Assurance expertise to help you to meet and exceed quality, safety and regulatory standards.
COVID-19 VACCINE OR THERAPEUTIC TESTING & DEVELOPMENT SUPPORT
IMMEDIATE QUESTION? Ask our experts now
FACTSHEET: COVID-19 Vaccine or Therapeutic Testing & Development Outsourcing
ARTICLE: Repurposing Vaccines for Intranasal Development
WEBINAR: Quality Control Strategy for Vaccine Development
WEBINAR: Repurposing Drugs for Inhaled Delivery
eBOOK: Contingency Outsourcing Solutions
NEW! Discover our Audit Live Tool for direct access to our scheduled audits
EVENT: 2nd Annual Inhaled and Nasal Biologics/DNA Forum - REGISTRATION IS LIVE
VIDEO:EXTRACTABLES/LEACHABLES LAB TOUR - Request access
WORKSHOP: How to Build an Inhaler (RDD 2023)
PRESENTATION:E&L Strategies (3rd Annual Extractables & Leachables Conference)
TALK: Medical Device Extractables & Leachables Studies
TALK: ID and sensitivity issues during E&L studies
ARTICLE: Glycosylation Analytical Approaches for Antibody Therapeutics
APP NOTE: Rapid Determination of Low/Trace Level Benzene in Pharmaceutical Excipients and Finished Products
ARTICLE: Importance of Aligning a Pharma Audit Scope with the Correct Standard
TALK: mRNA Analytics: Capping Efficiency, Sequencing, Poly-A Tail, dsRNA
LCMS Validated Assays List
For more information, download hereIntertek Pharmaceutical Services Manchester
P.O. Box 42
Hexagon Tower
Blackley
Manchester, M9 8ZS
United Kingdom
For location use: M9 8GQ
Intertek Pharmaceutical Services
10420 Wateridge Circle,
San Diego, CA, 92121
USA
ARTICLES
New Approaches to Bioassay Design
Characterisation of Bispecifics
The Significance and Challenges of Inhaled and Nasal Biologics
Monoclonal Antibody Characterisation - Addressing CQAs
Current Analytical Approaches to Biophysical Characterisation
Biosimilar Characterisation and Immunogenicity
WHITEPAPER DOWNLOADS
GMP Flow Cytometry: Applications, Considerations and Challenges
Liposome Physicochemical Property Analysis
Formulation of Biologics for Inhaled and Nasal Delivery
The Complexities of Antibody Drug Conjugate Characterization
BROCHURES
Download: Intertek Biopharmaceutical Services Brochure
Download: Intertek Pharmaceutical Services